Association of a protease (plasminogen activator) with a specific membrane fraction isolated from transformed cells
about
Lymphocyte-specific Ca2+-binding protein LSP1 is associated with the cytoplasmic face of the plasma membraneThe urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodelingA 170-kDa membrane-bound protease is associated with the expression of invasiveness by human malignant melanoma cellsTransformation phenotype of polyoma virus-transformed rat fibroblasts: plasminogen activator production is modulated by the growth state of the cells and regulated by the expression of an early viral gene function.Production of plasminogen activator by migrating cephalic neural crest cellsDirect fluorescent assay of urokinase and plasminogen activators of normal and malignant cells: kinetics and inhibitor profiles.Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradationLimited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells.Antipain and leupeptin restrict uterine DNA synthesis and function in mice.Synthesis of a fibrinolytic activator and inhibitor by endothelial cells.The urokinase receptor: involvement in cell surface proteolysis and cancer invasion.Urokinase-dependent adhesion loss and shape change after cyclic adenosine monophosphate elevation in cultured rat mesangial cells.Binding of urokinase to specific receptor sites on human breast cancer membranesIntroduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1Expression of transformation-associated protease(s) that degrade fibronectin at cell contact sitesThe extracellular matrix of normal chick embryo fibroblasts: its effect on transformed chick fibroblasts and its proteolytic degradation by the transformants.In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases.Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metalloprotease.Tumor cell proteinase visualization and quantification using a fluorescent transition-state analog probe.Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation.Production of plasminogen activator by human natural killer cells. Large granular lymphocytes.Differences in intracellular distribution of plasminogen activator in growing, confluent, and transformed 3T3 cellsTransformation-dependent activation of urokinase-type plasminogen activator by a plasmin-independent mechanism: involvement of cell surface membranes.Mechanism of dexamethasone inhibition of plasminogen activator in rat hepatoma cells.Detection and partial characterization of a chymostatin-sensitive endopeptidase in transformed fibroblasts.Down-regulation of epidermal growth factor receptor correlates with plasminogen activator activity in human A431 epidermoid carcinoma cells.A critical appraisal of the role of proteolytic enzymes in cancer invasion: emphasis on tumor surface proteinases.Interferon inhibits the release of plasminogen activator from SV3T3 cells.Fibronectin and the pericellular matrix of normal and transformed adherent cells.Site-directed mutagenesis of hamster complement C1S: characterization with an active form-specific antibody and possible involvement of C1S in tumorigenicity.Correlation between a specific molecular weight form of plasminogen activator and metabolic activity of 3T3 cells.Regulation of plasminogen activator in 3T3 cells: effect of phorbol myristate acetate on subcellular distribution and molecular weightDistinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells.In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion.Human neutrophil plasminogen activator is localized in specific granules and is translocated to the cell surface by exocytosis.Immunohistochemical localisation of tissue plasminogen activator in human brain tumours.
P2860
Q24633652-313A8CC2-D60A-4225-B9FD-E903952DEDDBQ28257803-8BFCBED2-FC51-4A9E-A60C-28C2C8940D86Q33862813-7A7613EF-3FA1-4F05-8A9B-163D35C7D3F3Q33923706-E6D090AA-A98F-44AC-A2B6-3687BB37284DQ33931354-F785985C-9722-476B-9457-471A81B87ABFQ33961219-8AC59C83-024A-46AD-87D7-2AB39BEFD0E6Q34605946-61F17333-73CC-402F-8F71-B599ECD3DD7FQ34617970-1A6A46E0-4248-4A44-885D-417EB6B37F5FQ35049362-B5554EF8-7719-4C08-A9BB-42D6DD4E9CF7Q35051369-C0106DFA-F7E9-44AA-B623-D329351DF003Q35240620-2293EAEA-1EC7-4543-A1A8-814CF98C51A4Q35594636-E225D572-3564-44E3-9FCA-8A190D6E70D3Q36027615-D89BB18C-A51D-4907-B4EF-E6A1B3C6CE43Q36072526-E3E1BEA6-61F2-4282-B7CE-78B0C425E591Q36210510-BB9F362F-1AC0-4E8B-A774-96CD45C44AAEQ36213680-7AB4AA87-9F6D-4C29-9D71-0DD117BE3C0AQ36220034-72D70C07-0623-4B86-B19A-0EABF43217FDQ36220992-EC14178D-18B3-4BE4-96AC-D9139D28EFE2Q36249478-51190CF8-3DE4-4CFE-91E8-F50206AE9949Q36347357-13765B6F-A9A9-4F28-A7D6-B0ACE1FA47C7Q36348579-CBA8B118-E2F7-482F-9697-8582AB424E78Q37311345-2EFB2412-8B84-4D07-9744-E04EFFE85328Q37587623-724E4EB5-331D-44F4-A318-1476434706CFQ37596869-65DB9C63-FBD2-4F48-A8BC-86692BC5A226Q37601307-20CE4347-8722-4562-9F24-2896284ED8C6Q37609171-1ACA83E4-FADB-4255-99FB-A15A82926726Q39644783-F7559083-EB94-4CE7-A3C7-97721F10BAB1Q40191453-E61EB4E7-C649-4D7E-BB7A-960EBFEC66A5Q40618354-41DFCE62-5D64-4A0B-9F45-B0A32F3FE596Q41192366-2FC9470B-32CC-40AF-9D2F-89DEA80573DBQ41361452-CC756749-361C-4D42-8399-17E7A8CAF09EQ41361782-8D643004-39AE-4AF0-8BE9-B86B9335726EQ41514749-EBA6A0FC-80CB-43B4-843C-3904202CDB1CQ42030493-2BAEBFF6-5EA6-4199-99B2-68079726D196Q42134600-6CC824B4-3E36-47C0-B880-0051DC2A1D23Q43050969-76EEEE9F-6737-4EAB-9C8F-87F16B9DD26B
P2860
Association of a protease (plasminogen activator) with a specific membrane fraction isolated from transformed cells
description
1976 nî lūn-bûn
@nan
1976 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1976 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
name
Association of a protease (pla ...... solated from transformed cells
@ast
Association of a protease (pla ...... solated from transformed cells
@en
type
label
Association of a protease (pla ...... solated from transformed cells
@ast
Association of a protease (pla ...... solated from transformed cells
@en
prefLabel
Association of a protease (pla ...... solated from transformed cells
@ast
Association of a protease (pla ...... solated from transformed cells
@en
P2860
P356
P1476
Association of a protease (pla ...... solated from transformed cells
@en
P2093
Quigley JP
P2860
P304
P356
10.1083/JCB.71.2.472
P407
P577
1976-11-01T00:00:00Z